Stock fact sheet · data as of

SS Innovations International, Inc. (SSII): fair value, margin of safety and Wheel Score

Healthcare · Medical - Devices · United States · Speculative / Distressed

Close2.70
GLS fair value-no model value
Margin of safety-
Wheel Score26No optionscapped: no options
Health1/9Piotroski F-score
Moat2.6/10GLS 10-year score
Market cap$541M27k shares a day
Implied vol.-no listed options
P/E-EPS -0.06
Dividend yieldnone
Beta0.73moves less than the market
Next earnings27 Oct 2026in 11 days (before the open)

Is SSII undervalued?

SS Innovations International, Inc. (SSII) closed at 2.70 on 16 Oct 2026. None of the nine GLS valuation models produced a positive value for the stock - the company lost money over the last twelve months, EPS -0.06 and it pays no dividend - so there is no GLS average fair value and no margin of safety to report. The quality, option and event numbers below still apply; the Quote page's Wall Street View shows what analysts expect instead.

The nightly engine files SSII under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for SSII

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF--Present value of the projected free cash flows, discounted at the cost of capital; no value tonight
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth--Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight
Lynch--EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight
GLS Growth--EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight
10 Cap--Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%; no value tonight
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV--Earnings power value: current EPS capitalised at 9% with no growth; no value tonight
Zombie (liquidation)0.0638-98%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target7.00+159%Analysts' average 12-month price target. Not in the average

Quality and financial health

Financial health is weak: SSII passes 1 of the nine Piotroski tests. Our screens drop the stock at the health rule; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is low at 2.6 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.

Returns on capital are thin or negative - ROIC -23.1%, ROE -31.7%, ROA -16.3% - with debt at 0.38 times equity and negative free cash flow.

SS Innovations International, Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from System Sales 100% (quarter Q2 FY2026).

Institutional ownership scores 1/10, insider activity 10/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score1 / 9ROIC-23.1%
GLS Moat2.6 / 10ROE-31.7%
Debt / equity0.38ROA-16.3%
Free-cash-flow yield-3.4%Payout ratio0%
Institutions1 / 10Insiders · Congress10 · 5 / 10

Wheel Score 26: No options

SSII has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (26 here). The valuation and quality numbers still apply to owning the shares outright.

Volume runs at 27k shares a day on a market cap of $541M, with a beta of 0.73 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 7 of 20.

PartPointsFrom
Value13 / 250% margin of safety
Health2 / 20Piotroski 1/9
Moat4 / 15moat 2.6/10
Premium0 / 20no option data
Stability7 / 2027k shares/day, $541M cap, beta 0.73

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

SS Innovations International, Inc. reports earnings on 27 Oct 2026 (before the open) - inside the 14-day window the Sunday Scan avoids, because a put sold now would carry the report's gap risk.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Medical - Devices

The 12 companies below are the closest to SS Innovations International, Inc. by market cap within the Medical - Devices industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
DCTH
Delcath Systems, Inc.
14.812.19-576%41Weak$514M
TCMD
Tactile Systems Technology, Inc.
22.4140.62+45%75Good$508M
KIDS
OrthoPediatrics Corp.
22.571.14-1883%44Weak$589M
PACB
Pacific Biosciences of California, Inc.
1.99--38Weak$619M
AVR
Anteris Technologies Global Corp.
6.36--45Weak$620M
CERS
Cerus Corporation
2.262.60+13%45Weak$455M
SGHT
Sight Sciences, Inc.
8.251.60-415%22Weak$454M
NPCE
NeuroPace, Inc.
12.78--40Weak$439M
SENS
Senseonics Holdings, Inc.
8.10--45Weak$428M
CTKB
Cytek Biosciences, Inc.
5.412.54-113%42Weak$703M
OFIX
Orthofix Medical Inc.
9.59--45Weak$388M
BBNX
Beta Bionics, Inc.
17.31--42Weak$779M

⚖ Compare SSII with 7 of them   All Healthcare stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about SSII

Is SSII undervalued right now?

The GLS models could not value SSII (the company lost money over the last twelve months, EPS -0.06 and it pays no dividend), so there is no fair value or margin of safety to compare the price of 2.70 against.

What is the Wheel Score of SSII and what does it mean?

SSII has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for SSII?

None of the nine GLS models produced a positive value for SSII (the company lost money over the last twelve months, EPS -0.06 and it pays no dividend), so there is no GLS fair value tonight.

When does SS Innovations International, Inc. report earnings next?

The next earnings report is due on 27 Oct 2026 (before the open), 11 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.

Does SSII have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on SSII, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.